Samantha Shalom - Profile and Investment Details

Investor Profile

Samantha Shalom is a Venture Capital based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences, Ori Biotech, Candel, Scitara, SeLux DiagnosticsGeneral Automation Lab Technologies, Personal Genome Diagnostics, Artisan Bio, Ultivue, Sherlock Biosciences, StrideBio, Intabio, Inflammatix, Codex DNA, Refeyn, Encodia, Aro Biotherapeutics, SpeeDx, Triumvira Immunologics, Vestaron, Scipher Medicine, IsoPlexis, Delfi Diagnostics, ChromaCode, Vizgen, DiCE Molecules, Octave Bioscience, Hawthorne Effect, 908 Devices, DNAnexus, Teckro, . Over time, Samantha Shalom has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Samantha Shalom is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Alternative Medicine, Wellness, Women Founded, Enterprise Software, Customer Engagement, Community Development, Transportation, Urban Development, Test and Measurement, Artificial Intelligence (AI), Retail, Information Technology (IT), Analytics, Bioinformatics, Software, Biotechnology, Construction, Internet Service Providers, Consumer Software, Home Care, Logistics, Health Diagnostics, Medical, Big Data, Information Technology, B2B, Real Estate, Therapeutics, Personal Health, Pharmaceuticals may find it worthwhile to explore potential connections with Samantha Shalom, as their portfolio suggests a familiarity and interest in this area.

Understanding Samantha Shalom’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.